Truist Securities Reiterates Buy Rating on Allogene (ALLO)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
Allogene (ALLO) PT Lowered to $7 at B.Riley
May 14, 2024 7:33 AM EDT(Updated - May 14, 2024 7:34 AM EDT)
B.Riley analyst Kalpit Patel lowered the price target on Allogene (NASDAQ: ALLO) to $7.00 (from $10.00) while maintaining a Buy rating.
The analyst commented: "On Monday (5/13), Allogene Therapeutics reported 1Q24 earnings and provided a corporate update.... More
Allogene (ALLO) PT Raised to $4.60 at Stifel
May 14, 2024 3:05 AM EDTStifel analyst Benjamin Burnett raised the price target on Allogene (NASDAQ: ALLO) to $4.60 (from $4.40) while maintaining a Hold rating.... More
Allogene Therapeutics (ALLO) Announces Pricing of $110 million Offering of Common Stock
May 13, 2024 4:48 PM EDTAllogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T) products for cancer and autoimmune disease, today announced the pricing of an underwritten offering of 37,931,035 shares of its common stock at a price of $2.90 per share.... More
Allogene Therapeutics, Inc. (ALLO) Tops Q1 EPS by 3c
May 13, 2024 4:13 PM EDTAllogene Therapeutics, Inc. (NASDAQ: ALLO) reported Q1 EPS of ($0.38), $0.03 better than the analyst estimate of ($0.41).
For earnings history and earnings-related data on Allogene Therapeutics, Inc. (ALLO) click here.
... More